Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules.

K. Temming, M. Lacombe, H.E. Moorlag, S.A. Asgeirsdottir, L. Orfi, G. Kéri, K. Poelstra, G. Molema, R.J. Kok

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e57
JournalJournal of Controlled Release
Volume116
Issue number2
DOIs
Publication statusPublished - 2006

Keywords

  • albuminoid
  • arginylglycylaspartic acid
  • drug carrier
  • oligopeptide
  • phthalazine derivative
  • pyridine derivative
  • vasculotropin A
  • vatalanib
  • article
  • binding competition
  • cell culture
  • chemistry
  • drug antagonism
  • drug delivery system
  • drug effect
  • endothelium cell
  • human
  • metabolism
  • methodology

Cite this